Distinct brain structure and behavior related to ADHD and conduct disorder traits.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
11 2020
Historique:
received: 16 04 2017
accepted: 05 04 2018
revised: 22 03 2018
pubmed: 16 8 2018
medline: 16 3 2021
entrez: 16 8 2018
Statut: ppublish

Résumé

Attention-Deficit/Hyperactivity Disorder (ADHD) and conduct disorder (CD) exemplify top-down dysregulation conditions that show a large comorbidity and shared genetics. At the same time, they entail two different types of symptomology involving mainly non-emotional or emotional dysregulation. Few studies have tried to separate the specific biology underlying these two dimensions. It has also been suggested that both types of conditions consist of extreme cases in the general population where the symptoms are widely distributed. Here we test whether brain structure is specifically associated to ADHD or CD symptoms in a general population of adolescents (n = 1093) being part of the IMAGEN project. Both ADHD symptoms and CD symptoms were related to similar and overlapping MRI findings of a smaller structure in prefrontal and anterior cingulate cortex. However, our regions of interest (ROI) approach indicated that gray matter volume (GMV) and surface area (SA) in dorsolateral/dorsomedial prefrontal cortex and caudal anterior cingulate cortex were negatively associated to ADHD symptoms when controlling for CD symptoms while rostral anterior cingulate cortex GMV was negatively associated to CD symptoms when controlling for ADHD symptoms. The structural findings were mirrored in performance of neuropsychological tests dependent on prefrontal and anterior cingulate regions, showing that while performance on the Stop Signal test was specifically related to the ADHD trait, delayed discounting and working memory were related to both ADHD and CD traits. These results point towards a partially domain specific and dimensional capacity in different top-down regulatory systems associated with ADHD and CD symptoms.

Identifiants

pubmed: 30108313
doi: 10.1038/s41380-018-0202-6
pii: 10.1038/s41380-018-0202-6
pmc: PMC7577834
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3020-3033

Subventions

Organisme : Medical Research Council
ID : MR/N027558/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0700704
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH085772
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : Medical Research Council
ID : MR/N000390/1
Pays : United Kingdom

Références

Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121:65–94.
pubmed: 9000892 doi: 10.1037/0033-2909.121.1.65
Petrovic P, Castellanos FX. Top-down dysregulation–from ADHD to emotional instability. Front Behav Neurosci. 2016;10:1–25.
Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry. 2005;57:1336–46.
pubmed: 15950006 doi: 10.1016/j.biopsych.2005.02.006
Blair RJ, Leibenluft E, Pine DS. Conduct disorder and callous-unemotional traits in youth. N Engl J Med. 2014;371:2207–16.
pubmed: 25470696 pmcid: 6312699 doi: 10.1056/NEJMra1315612
Glenn AL, Johnson AK, Raine A. Antisocial personality disorder: a current review. Curr Psychiatry Rep. 2013;15:427.
pubmed: 24249521 doi: 10.1007/s11920-013-0427-7
Rubia K. “Cool” inferior frontostriatal dysfunction in attention-deficit/hyperactivity disorder versus “hot” ventromedial orbitofrontal-limbic dysfunction in conduct disorder: a review. Biol Psychiatry. 2011;69:e69–87.
pubmed: 21094938 doi: 10.1016/j.biopsych.2010.09.023
Sebastian A, Jung P, Krause-Utz A, Lieb K, Schmahl C, Tuscher O. Frontal dysfunctions of impulse control - a systematic review in borderline personality disorder and attention-deficit/hyperactivity disorder. Front Hum Neurosci. 2014;8:698.
pubmed: 25232313 pmcid: 4153044 doi: 10.3389/fnhum.2014.00698
Anckarsater H, Stahlberg O, Larson T, Hakansson C, Jutblad SB, Niklasson L, et al. The impact of ADHD and autism spectrum disorders on temperament, character, and personality development. Am J Psychiatry. 2006;163:1239–44.
pubmed: 16816230 doi: 10.1176/ajp.2006.163.7.1239
Philipsen A, Limberger MF, Lieb K, Feige B, Kleindienst N, Ebner-Priemer U, et al. Attention-deficit hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry. 2008;192:118–23.
pubmed: 18245028 doi: 10.1192/bjp.bp.107.035782
Semiz UB, Basoglu C, Oner O, Munir KM, Ates A, Algul A, et al. Effects of diagnostic comorbidity and dimensional symptoms of attention-deficit-hyperactivity disorder in men with antisocial personality disorder. Aust N Z J Psychiatry. 2008;42:405–13.
pubmed: 18473259 pmcid: 3166642 doi: 10.1080/00048670801961099
Storebo OJ, Simonsen E. The association between ADHD and Antisocial Personality Disorder (ASPD): a review. J Atten Disord. 2013;20:815–24.
pubmed: 24284138 doi: 10.1177/1087054713512150
Distel MA, Carlier A, Middeldorp CM, Derom CA, Lubke GH, Boomsma DI. Borderline personality traits and adult attention-deficit hyperactivity disorder symptoms: a genetic analysis of comorbidity. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:817–25.
pubmed: 21812103 doi: 10.1002/ajmg.b.31226
Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748–51.
pubmed: 20595427 doi: 10.1176/appi.ajp.2010.09091379
Crosbie J, Arnold P, Paterson A, Swanson J, Dupuis A, Li X, et al. Response inhibition and ADHD traits: correlates and heritability in a community sample. J Abnorm Child Psychol. 2013;41:497–507.
pubmed: 23315233 pmcid: 3600128 doi: 10.1007/s10802-012-9693-9
Das D, Cherbuin N, Butterworth P, Anstey KJ, Easteal S. A population-based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adults. PLoS ONE. 2012;7:e31500.
pubmed: 22347487 pmcid: 3275565 doi: 10.1371/journal.pone.0031500
Petrovic P, Ekman CJ, Klahr J, Tigerstrom L, Ryden G, Johansson AG, et al. Significant grey matter changes in a region of the orbitofrontal cortex in healthy participants predicts emotional dysregulation. Soc Cogn Affect Neurosci. 2015;11:1041–9.
pubmed: 26078386 pmcid: 4927027 doi: 10.1093/scan/nsv072
Castellanos FX, Sonuga-Barke EJ, Milham MP, Tannock R. Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci. 2006;10:117–23.
pubmed: 16460990 doi: 10.1016/j.tics.2006.01.011
Castellanos FX, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci. 2002;3:617–28.
pubmed: 12154363 doi: 10.1038/nrn896
Shaw P, Stringaris A, Nigg J, Leibenluft E. Emotion dysregulation in attention deficit hyperactivity disorder. Am J Psychiatry. 2014;171:276–93.
pubmed: 24480998 pmcid: 4282137 doi: 10.1176/appi.ajp.2013.13070966
Alderson RM, Rapport MD, Kofler MJ. Attention-deficit/hyperactivity disorder and behavioral inhibition: a meta-analytic review of the stop-signal paradigm. J Abnorm Child Psychol. 2007;35:745–58.
pubmed: 17668315 doi: 10.1007/s10802-007-9131-6
Lansbergen MM, Kenemans JL, van Engeland H. Stroop interference and attention-deficit/hyperactivity disorder: a review and metaanalysis. Neuropsychology. 2007;21:251–62.
pubmed: 17402825 doi: 10.1037/0894-4105.21.2.251
Nichols SL, Waschbusch DA. A review of the validity of laboratory cognitive tasks used to assess symptoms of ADHD. Child Psychiatry Hum Dev. 2004;34:297–315.
pubmed: 15039603 doi: 10.1023/B:CHUD.0000020681.06865.97
Bush G. Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2011;69:1160–7.
pubmed: 21489409 pmcid: 3109164 doi: 10.1016/j.biopsych.2011.01.022
Cieslik EC, Mueller VI, Eickhoff CR, Langner R, Eickhoff SB. Three key regions for supervisory attentional control: evidence from neuroimaging meta-analyses. Neurosci Biobehav Rev. 2015;48:22–34.
pubmed: 25446951 doi: 10.1016/j.neubiorev.2014.11.003
Nee DE, Wager TD, Jonides J. Interference resolution: insights from a meta-analysis of neuroimaging tasks. Cogn Affect Behav Neurosci. 2007;7:1–17.
pubmed: 17598730 doi: 10.3758/CABN.7.1.1
Cortese S, Kelly C, Chabernaud C, Proal E, Di Martino A, Milham MP, et al. Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. Am J Psychiatry. 2012;169:1038–55.
pubmed: 22983386 doi: 10.1176/appi.ajp.2012.11101521
Dickstein SG, Bannon K, Castellanos FX, Milham MP. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry. 2006;47:1051–62.
pubmed: 17073984 doi: 10.1111/j.1469-7610.2006.01671.x
Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry. 2013;70:185–98.
pubmed: 23247506 doi: 10.1001/jamapsychiatry.2013.277
Norman LJ, Carlisi C, Lukito S, Hart H, Mataix-Cols D, Radua J, et al. Structural and functional brain abnormalities in attention-deficit/hyperactivity disorder and obsessive-compulsive disorder: a comparative meta-analysis. JAMA Psychiatry. 2016;73:815–25.
pubmed: 27276220 doi: 10.1001/jamapsychiatry.2016.0700
Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA. 2007;104:19649–54.
pubmed: 18024590 doi: 10.1073/pnas.0707741104 pmcid: 2148343
Shaw P, Malek M, Watson B, Greenstein D, de Rossi P, Sharp W. Trajectories of cerebral cortical development in childhood and adolescence and adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 2013;74:599–606.
pubmed: 23726514 pmcid: 5922431 doi: 10.1016/j.biopsych.2013.04.007
Seidman LJ, Biederman J, Liang L, Valera EM, Monuteaux MC, Brown A, et al. Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry. Biol Psychiatry. 2011;69:857–66.
pubmed: 21183160 doi: 10.1016/j.biopsych.2010.09.053
Frodl T, Skokauskas N. Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand. 2012;125:114–26.
pubmed: 22118249 doi: 10.1111/j.1600-0447.2011.01786.x
Nakao T, Radua J, Rubia K, Mataix-Cols D. Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am J Psychiatry. 2011;168:1154–63.
pubmed: 21865529 doi: 10.1176/appi.ajp.2011.11020281
Enzi B, Doering S, Faber C, Hinrichs J, Bahmer J, Northoff G. Reduced deactivation in reward circuitry and midline structures during emotion processing in borderline personality disorder. World J Biol Psychiatry. 2013;14:45–56.
pubmed: 21732733 doi: 10.3109/15622975.2011.579162
Holtmann J, Herbort MC, Wustenberg T, Soch J, Richter S, Walter H, et al. Trait anxiety modulates fronto-limbic processing of emotional interference in borderline personality disorder. Front Hum Neurosci. 2013;7:54.
pubmed: 23459637 pmcid: 3585713 doi: 10.3389/fnhum.2013.00054
Jacob GA, Zvonik K, Kamphausen S, Sebastian A, Maier S, Philipsen A, et al. Emotional modulation of motor response inhibition in women with borderline personality disorder: an fMRI study. J Psychiatry Neurosci. 2013;38:164–72.
pubmed: 23046830 pmcid: 3633709 doi: 10.1503/jpn.120029
Lang S, Kotchoubey B, Frick C, Spitzer C, Grabe HJ, Barnow S. Cognitive reappraisal in trauma-exposed women with borderline personality disorder. Neuroimage. 2012;59:1727–34.
pubmed: 21907809 doi: 10.1016/j.neuroimage.2011.08.061
Schulze L, Domes G, Kruger A, Berger C, Fleischer M, Prehn K, et al. Neuronal correlates of cognitive reappraisal in borderline patients with affective instability. Biol Psychiatry. 2011;69:564–73.
pubmed: 21195392 doi: 10.1016/j.biopsych.2010.10.025
Silbersweig D, Clarkin JF, Goldstein M, Kernberg OF, Tuescher O, Levy KN, et al. Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. Am J Psychiatry. 2007;164:1832–41.
pubmed: 18056238 doi: 10.1176/appi.ajp.2007.06010126
Wingenfeld K, Rullkoetter N, Mensebach C, Beblo T, Mertens M, Kreisel S, et al. Neural correlates of the individual emotional Stroop in borderline personality disorder. Psychoneuroendocrinology. 2009;34:571–86.
pubmed: 19042093 doi: 10.1016/j.psyneuen.2008.10.024
Soloff P, Nutche J, Goradia D, Diwadkar V. Structural brain abnormalities in borderline personality disorder: a voxel-based morphometry study. Psychiatry Res. 2008;164:223–36.
pubmed: 19019636 pmcid: 3286221 doi: 10.1016/j.pscychresns.2008.02.003
Soloff PH, Pruitt P, Sharma M, Radwan J, White R, Diwadkar VA. Structural brain abnormalities and suicidal behavior in borderline personality disorder. J Psychiatr Res. 2012;46:516–25.
pubmed: 22336640 pmcid: 3307855 doi: 10.1016/j.jpsychires.2012.01.003
Yang Y, Raine A. Prefrontal structural and functional brain imaging findings in antisocial, violent, and psychopathic individuals: a meta-analysis. Psychiatry Res. 2009;174:81–8.
pubmed: 19833485 pmcid: 2784035 doi: 10.1016/j.pscychresns.2009.03.012
Rogers JC, De Brito SA. Cortical and subcortical gray matter volume in youths with conduct problems: a meta-analysis. JAMA Psychiatry. 2016;73:64–72.
pubmed: 26650724 doi: 10.1001/jamapsychiatry.2015.2423
Sebastian CL, De Brito SA, McCrory EJ, Hyde ZH, Lockwood PL, Cecil CA, et al. Grey matter volumes in children with conduct problems and varying levels of callous-unemotional traits. J Abnorm Child Psychol. 2016;44:639–49.
pubmed: 26364620 doi: 10.1007/s10802-015-0073-0
Schumann G, Loth E, Banaschewski T, Barbot A, Barker G, Buchel C, et al. The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry. 2010;15:1128–39.
pubmed: 21102431 doi: 10.1038/mp.2010.4
Albaugh M, Orr C, Chaarani B, Althoff R, Allgaier N, D’Alberto N, et al. Inattention and reaction time variability are linked to ventromedial prefrontal volume in adolescents. Biol Psychiatry. 2017;82:660–8.
doi: 10.1016/j.biopsych.2017.01.003
Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci. 2015;16:403–18.
pubmed: 26087681 pmcid: 6013051 doi: 10.1038/nrn3976
Wager TD, Davidson ML, Hughes BL, Lindquist MA, Ochsner KN. Prefrontal-subcortical pathways mediating successful emotion regulation. Neuron. 2008;59:1037–50.
pubmed: 18817740 pmcid: 2742320 doi: 10.1016/j.neuron.2008.09.006
Goodman R. Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry. 2001;40:1337–45.
pubmed: 11699809 doi: 10.1097/00004583-200111000-00015
Carroll JM, Maughan B, Goodman R, Meltzer H. Literacy difficulties and psychiatric disorders: evidence for comorbidity. J Child Psychol Psychiatry. 2005;46:524–32.
pubmed: 15845132 doi: 10.1111/j.1469-7610.2004.00366.x
Schilling C, Kuhn S, Paus T, Romanowski A, Banaschewski T, Barbot A, et al. Cortical thickness of superior frontal cortex predicts impulsiveness and perceptual reasoning in adolescence. Mol Psychiatry. 2013;18:624–30.
pubmed: 22665261 doi: 10.1038/mp.2012.56
Panizzon MS, Fennema-Notestine C, Eyler LT, Jernigan TL, Prom-Wormley E, Neale M, et al. Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex. 2009;19:2728–35.
pubmed: 19299253 pmcid: 2758684 doi: 10.1093/cercor/bhp026
Winkler AM, Kochunov P, Blangero J, Almasy L, Zilles K, Fox PT, et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage. 2010;53:1135–46.
pubmed: 20006715 doi: 10.1016/j.neuroimage.2009.12.028
Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage. 2012;61:1402–18.
pubmed: 22430496 doi: 10.1016/j.neuroimage.2012.02.084
Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, Salat DH, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex. 2004;14:11–22.
pubmed: 14654453 doi: 10.1093/cercor/bhg087
Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage. 1999;9:195–207.
pubmed: 9931269 doi: 10.1006/nimg.1998.0396
Fischl B, Salat DH, van der Kouwe AJ, Makris N, Segonne F, Quinn BT, et al. Sequence-independent segmentation of magnetic resonance images. Neuroimage. 2004;23(Suppl 1):S69–84.
pubmed: 15501102 doi: 10.1016/j.neuroimage.2004.07.016
Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA. 2000;97:11050–5.
pubmed: 10984517 doi: 10.1073/pnas.200033797 pmcid: 27146
Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. 1999;9:179–94.
pubmed: 9931268 doi: 10.1006/nimg.1998.0395
Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968–80.
pubmed: 16530430
Abe C, Ekman CJ, Sellgren C, Petrovic P, Ingvar M, Landen M. Manic episodes are related to changes in frontal cortex: a longitudinal neuroimaging study of bipolar disorder 1. Brain. 2015;138(Pt 11):3440–8.
pubmed: 26373602 doi: 10.1093/brain/awv266
Dennis M, Francis DJ, Cirino PT, Schachar R, Barnes MA, Fletcher JM. Why IQ is not a covariate in cognitive studies of neurodevelopmental disorders. J Int Neuropsychol Soc. 2009;15:331–43.
pubmed: 19402919 pmcid: 3075072 doi: 10.1017/S1355617709090481
Logan GD, Cowan WB, Davis KA. On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform. 1984;10:276–91.
pubmed: 6232345 doi: 10.1037/0096-1523.10.2.276
Verbruggen F, Logan GD, Stevens MA. STOP-IT: Windows executable software for the stop-signal paradigm. Behav Res Methods. 2008;40:479–83.
pubmed: 18522058 doi: 10.3758/BRM.40.2.479
Coull JT, Middleton HC, Robbins TW, Sahakian BJ. Contrasting effects of clonidine and diazepam on tests of working memory and planning. Psychopharmacology. 1995;120:311–21.
pubmed: 8524979 doi: 10.1007/BF02311179
Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol Med. 1999;29:527–38.
pubmed: 10405075 doi: 10.1017/S0033291799008338
Nymberg C, Banaschewski T, Bokde AL, Buchel C, Conrod P, Flor H, et al. DRD2/ANKK1 polymorphism modulates the effect of ventral striatal activation on working memory performance. Neuropsychopharmacology. 2014;39:2357–65.
pubmed: 24713612 pmcid: 4138745 doi: 10.1038/npp.2014.83
Kirby KN, Petry NM, Bickel WK. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen. 1999;128:78–87.
pubmed: 10100392 doi: 10.1037/0096-3445.128.1.78
Krause-Utz A, Oei NY, Niedtfeld I, Bohus M, Spinhoven P, Schmahl C, et al. Influence of emotional distraction on working memory performance in borderline personality disorder. Psychol Med. 2012;42:2181–92.
pubmed: 22397907 doi: 10.1017/S0033291712000153
Prehn K, Schulze L, Rossmann S, Berger C, Vohs K, Fleischer M, et al. Effects of emotional stimuli on working memory processes in male criminal offenders with borderline and antisocial personality disorder. World J Biol Psychiatry. 2013;14:71–8.
pubmed: 22381099 doi: 10.3109/15622975.2011.584906
Egner T, Etkin A, Gale S, Hirsch J. Dissociable neural systems resolve conflict from emotional versus nonemotional distracters. Cereb Cortex. 2008;18:1475–84.
pubmed: 17940084 doi: 10.1093/cercor/bhm179
Etkin A, Egner T, Peraza DM, Kandel ER, Hirsch J. Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron. 2006;51:871–82.
pubmed: 16982430 doi: 10.1016/j.neuron.2006.07.029
Ochsner KN, Hughes B, Robertson ER, Cooper JC, Gabrieli JD. Neural systems supporting the control of affective and cognitive conflicts. J Cogn Neurosci. 2009;21:1842–55.
pubmed: 18823233 pmcid: 6558970 doi: 10.1162/jocn.2009.21129
Rahm C, Liberg B, Wiberg-Kristoffersen M, Aspelin P, Msghina M. Rostro-caudal and dorso-ventral gradients in medial and lateral prefrontal cortex during cognitive control of affective and cognitive interference. Scand J Psychol. 2013;54:66–71.
pubmed: 23316801 doi: 10.1111/sjop.12023
Whalen PJ, Bush G, McNally RJ, Wilhelm S, McInerney SC, Jenike MA, et al. The emotional counting Stroop paradigm: a functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry. 1998;44:1219–28.
pubmed: 9861465 doi: 10.1016/S0006-3223(98)00251-0
Petrovic P, Dietrich T, Fransson P, Andersson J, Carlsson K, Ingvar M. Placebo in emotional processing--induced expectations of anxiety relief activate a generalized modulatory network. Neuron. 2005;46:957–69.
pubmed: 15953423
Schiller D, Delgado MR. Overlapping neural systems mediating extinction, reversal and regulation of fear. Trends Cogn Sci. 2010;14:268–76.
pubmed: 20493762 doi: 10.1016/j.tics.2010.04.002
Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA. 2004;101:8174–9.
pubmed: 15148381 doi: 10.1073/pnas.0402680101 pmcid: 419576
Yarkoni T, Poldrack RA, Nichols TE, Van Essen DC, Wager TD. Large-scale automated synthesis of human functional neuroimaging data. Nat Methods. 2011;8:665–70.
pubmed: 21706013 pmcid: 3146590 doi: 10.1038/nmeth.1635
Maier S, Perlov E, Graf E, Dieter E, Sobanski E, Rump M, et al. Discrete global but no focal gray matter volume reductions in unmedicated adult patients with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2016;80:905–15.
pubmed: 26115789 doi: 10.1016/j.biopsych.2015.05.012
Reuter M, Tisdall MD, Qureshi A, Buckner RL, van der Kouwe AJ, Fischl B. Head motion during MRI acquisition reduces gray matter volume and thickness estimates. Neuroimage. 2015;107:107–15.
pubmed: 25498430 doi: 10.1016/j.neuroimage.2014.12.006

Auteurs

Frida Bayard (F)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Charlotte Nymberg Thunell (C)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Christoph Abé (C)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Rita Almeida (R)

Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Tobias Banaschewski (T)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Gareth Barker (G)

Centre for Neuroimaging Sciences, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.

Arun L W Bokde (ALW)

Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.

Uli Bromberg (U)

University Medical Centre Hamburg-Eppendorf, House W34, 3.OG, Martinistr. 52, 20246, Hamburg, Germany.

Christian Büchel (C)

University Medical Centre Hamburg-Eppendorf, House W34, 3.OG, Martinistr. 52, 20246, Hamburg, Germany.

Erin Burke Quinlan (EB)

Centre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Sylvane Desrivières (S)

Centre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Herta Flor (H)

Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Department of Psychology, School of Social Sciences, University of Mannheim, 68131, Mannheim, Germany.

Vincent Frouin (V)

NeuroSpin, CEA, Université Paris-Saclay, F-91191, Gif-sur-Yvette, France.

Hugh Garavan (H)

Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, 05405, USA.

Penny Gowland (P)

Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, UK.

Andreas Heinz (A)

Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany.

Bernd Ittermann (B)

Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Berlin, Germany.

Jean-Luc Martinot (JL)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging and Psychiatry", University Paris Sud-Paris Saclay, University Paris Descartes; Service Hospitalier Frédéric Joliot, Orsay; and Maison de Solenn, Paris, France.

Marie-Laure Paillère Martinot (MP)

Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging and Psychiatry", University Paris Sud-Paris Saclay, University Paris Descartes; and AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris, France.

Frauke Nees (F)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Dimitri Papadopoulos Orfanos (DP)

NeuroSpin, CEA, Université Paris-Saclay, F-91191, Gif-sur-Yvette, France.

Tomáš Paus (T)

Rotman Research Institute, Baycrest and Departments of Psychology and Psychiatry, University of Toronto, Toronto, ON, M6A 2E1, Canada.

Luise Poustka (L)

Clinic for Child and Adolescent Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, von-Siebold-Str. 5, 37075, Göttingen, Germany.

Patricia Conrod (P)

Department of Psychiatry, Université de Montréal, CHU Ste Justine Hospital, Montréal, QC, Canada.

Argyris Stringaris (A)

National Institute of Mental Health, NIH, Bethesda, MD, 20892, USA.

Maren Struve (M)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Jani Penttilä (J)

Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland.

Viola Kappel (V)

Department of Child and Adolescent Psychiatry Psychosomatics and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany.

Yvonne Grimmer (Y)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Tahmine Fadai (T)

University Medical Centre Hamburg-Eppendorf, House W34, 3.OG, Martinistr. 52, 20246, Hamburg, Germany.

Betteke van Noort (B)

Department of Child and Adolescent Psychiatry Psychosomatics and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany.

Michael N Smolka (MN)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Nora C Vetter (NC)

Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany.

Henrik Walter (H)

Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany.

Robert Whelan (R)

School of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.

Gunter Schumann (G)

Centre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Predrag Petrovic (P)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. predrag.petrovic@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH